These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12449448)

  • 1. Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts.
    Mehra MR; Uber PA; Potluri S
    Am J Med Sci; 2002 Nov; 324(5):267-75. PubMed ID: 12449448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials.
    Hansen MR; Hróbjartsson A; Videbæk L; Ennis ZN; Pareek M; Paulsen NH; Broe M; Olesen M; Pottegård A; Damkier P; Hallas J
    Am J Med; 2020 Jun; 133(6):e280-e289. PubMed ID: 32173347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure.
    Valluri A; Struthers AD; Lang CC
    Curr Heart Fail Rep; 2014 Mar; 11(1):31-9. PubMed ID: 24234398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on recent clinical trials in congestive heart failure.
    Betkowski AS; Hauptman PJ
    Curr Opin Cardiol; 2000 Jul; 15(4):293-303. PubMed ID: 11139094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: what we know and current controversies.
    Moser DK; Biddle MJ
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):423-37, vii-viii. PubMed ID: 14717387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S; Kitakaze M
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor blockers in the treatment of heart failure.
    Peterson RC; Dunlap ME
    Congest Heart Fail; 2002; 8(5):246-50; 256. PubMed ID: 12368586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-treatment mismatch in the pharmacotherapy of heart failure.
    Lee DS; Tu JV; Juurlink DN; Alter DA; Ko DT; Austin PC; Chong A; Stukel TA; Levy D; Laupacis A
    JAMA; 2005 Sep; 294(10):1240-7. PubMed ID: 16160132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to blockade of the renin-angiotensin-aldosterone system: evidence from randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers--questions remain unsolved.
    Ueda S
    J Pharmacol Sci; 2010; 113(4):292-5. PubMed ID: 20675956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving clinical outcomes with drug treatment in heart failure: what have trials taught?
    Konstam MA
    Am J Cardiol; 2003 Mar; 91(6A):9D-14D. PubMed ID: 12670637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring new treatment strategies in heart failure.
    Swedberg K
    Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on therapy for heart failure.
    DiBianco R
    Am J Med; 2003 Oct; 115(6):480-8. PubMed ID: 14563505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin antagonism in patients with heart failure: ACE inhibitors, angiotensin receptor antagonists or both?
    Cruden NL; Newby DE
    Am J Cardiovasc Drugs; 2004; 4(6):345-53. PubMed ID: 15554719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure.
    Manohar P; Piña IL
    Mayo Clin Proc; 2003 Mar; 78(3):334-8. PubMed ID: 12630586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.